Cargando…

Adenosine in pancreatic cancer: Emerging combination therapies

Detalles Bibliográficos
Autores principales:	Roth, Susanne, Hackert, Thilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838397/ https://www.ncbi.nlm.nih.gov/pubmed/31590927 http://dx.doi.org/10.1016/j.ebiom.2019.09.030

Ejemplares similares

Surgery for Pancreatic Cancer after neoadjuvant treatment
por: Hackert, Thilo
Publicado: (2018)

Triple combination therapy for pancreatic cancer remodels stroma and improves survival
por: Vázquez-Arreguín, Karina, et al.
Publicado: (2023)

State-of-the-art surgery for pancreatic cancer
por: Nießen, Anna, et al.
Publicado: (2021)

Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment
por: Klaiber, Ulla, et al.
Publicado: (2020)

Current State of Surgical Management of Pancreatic Cancer
por: Hackert, Thilo, et al.
Publicado: (2011)

ASO Author Reflections: Prediction of the Chemotherapy Effect on the Prognosis of Locally Advanced Pancreatic Cancer
por: Tanaka, Masayuki, et al.
Publicado: (2022)

Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer
por: Roth, Susanne, et al.
Publicado: (2020)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
por: Wei, Kongyuan, et al.
Publicado: (2021)

Current State of Vascular Resections in Pancreatic Cancer Surgery
por: Hackert, Thilo, et al.
Publicado: (2015)

Pancreatic Cancer: Targeted Therapy Holds the Promise
por: Zhou, Zhijun, et al.
Publicado: (2021)

Enormously dilated pancreatic duct
por: Koschny, Ronald, et al.
Publicado: (2022)

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?
por: Furuse, Junji
Publicado: (2019)

Autoimmune Pancreatitis: The Emerging Role of Serologic Biomarkers
por: Wiley, John W., et al.
Publicado: (2009)

Clinical Impact of Molecular Subtyping of Pancreatic Cancer
por: Zhou, Xu, et al.
Publicado: (2021)

Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target
por: Wolters-Eisfeld, Gerrit, et al.
Publicado: (2023)

Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
por: Zhou, Xu, et al.
Publicado: (2023)

Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study
por: Roth, Susanne, et al.
Publicado: (2019)

Adenosine 5’-triphosphate’s role in bradycardia and syncope associated with pulmonary embolism
por: Pelleg, Amir, et al.
Publicado: (2018)

Adipokines and central control in adenosine A1 receptor dependent glucose metabolism
por: Faulhaber-Walter, Robert
Publicado: (2012)

Crystal structures of the A(2A) adenosine receptor and their use in medicinal chemistry
por: Jacobson, Kenneth A
Publicado: (2013)

Chemical Therapy for Chronic Pancreatitis: An Assumption or an Alternative?
por: Jiang, Xi, et al.
Publicado: (2023)

mSphere of Influence: Adenosine in Host Defense against Bacterial Pneumonia—Friend or Foe?
por: Bou Ghanem, Elsa N.
Publicado: (2019)

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy
por: Icard, Philippe, et al.
Publicado: (2018)

Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
por: Kleeff, Jörg, et al.
Publicado: (2019)

Novel mechanism of impaired metabolism‐secretion coupling in β‐cells: Loss of cytosolic adenosine triphosphate by leakage
por: Fujimoto, Shimpei
Publicado: (2019)

Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis
por: Fritz, Stefan, et al.
Publicado: (2008)

Epithelial-to-Mesenchymal Transition in Pancreatic Cancer is associated with Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging
por: Mayer, Philipp, et al.
Publicado: (2021)

Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming
por: Wang, Zhe, et al.
Publicado: (2019)

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
por: Leary, Alexandra F, et al.
Publicado: (2007)

Familial Pancreatic Cancer: To Screen or not to Screen?
por: Vasen, Hans F.A., et al.
Publicado: (2015)

2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer
por: Russo, Suzanne, et al.
Publicado: (2016)

CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells
por: Wang, Zhe, et al.
Publicado: (2016)

Targeting the adenosine 2A receptor in non-small cell lung cancer: shooting with blank bullets?
por: Garcia-Lorenzo, Esther, et al.
Publicado: (2023)

Overcoming acquired chemo-resistance to gemcitabine: implications from the perspective of multi-modal therapy including surgery for pancreatic cancer
por: Motoi, Fuyuhiko
Publicado: (2021)

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients
por: Ahmed, Azaz, et al.
Publicado: (2023)

Potential linkage between dipeptidyl peptidase‐4 inhibitor use and the risk of pancreatitis/pancreatic cancer
por: Shirakawa, Jun, et al.
Publicado: (2020)

Emerging novel therapies against paracetamol (acetaminophen) hepatotoxicity
por: Jaeschke, Hartmut
Publicado: (2019)

Ketogenic Therapy in Serious Mental Illness: Emerging Evidence
por: Sarnyai, Zoltán, et al.
Publicado: (2020)

Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
por: Naumann, Patrick, et al.
Publicado: (2019)

Endoscopic Ultrasonography for Vascular Invasion in Pancreatic Cancer
por: Kim, Seong-Hun
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pvvuj0be5qfu8k7mc4hem9mkit